Annual Operating Margin
-163.13%
+27.52%+14.43%
December 31, 2023
Summary
- As of February 8, 2025, EYPT annual operating profit margin is -163.13%, with the most recent change of +27.52% (+14.43%) on December 31, 2023.
- During the last 3 years, EYPT annual operating margin has fallen by -54.85% (-50.66%).
- EYPT annual operating margin is now -513.62% below its all-time high of 39.44%, reached on June 30, 2010.
Performance
EYPT Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-311.17%
+53.35%+14.64%
September 30, 2024
Summary
- As of February 8, 2025, EYPT quarterly operating profit margin is -311.17%, with the most recent change of +53.35% (+14.64%) on September 30, 2024.
- Over the past year, EYPT quarterly operating margin has dropped by -216.46% (-228.55%).
- EYPT quarterly operating margin is now -478.78% below its all-time high of 82.15%, reached on September 30, 2014.
Performance
EYPT Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
EYPT Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.4% | -228.6% |
| 3 y3 years | -50.7% | -42.3% |
| 5 y5 years | +80.5% | -42.3% |
EYPT Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.0% | +14.4% | -228.6% | +14.6% |
| 5 y | 5-year | -50.7% | +30.6% | -2395.3% | +14.6% |
| alltime | all time | -513.6% | +96.6% | -478.8% | +97.9% |
EyePoint Pharmaceuticals Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -311.17%(-14.6%) |
| Jun 2024 | - | -364.52%(+27.8%) |
| Mar 2024 | - | -285.18%(+144.6%) |
| Dec 2023 | -163.13%(-14.4%) | -116.58%(+23.1%) |
| Sep 2023 | - | -94.71%(-62.1%) |
| Jun 2023 | - | -249.98%(-10.9%) |
| Mar 2023 | - | -280.54%(+28.3%) |
| Dec 2022 | -190.65%(+27.4%) | -218.70%(+19.0%) |
| Sep 2022 | - | -183.76%(+10.6%) |
| Jun 2022 | - | -166.16%(-15.5%) |
| Mar 2022 | - | -196.73%(+25.8%) |
| Dec 2021 | -149.64%(+38.2%) | -156.36%(-7.5%) |
| Sep 2021 | - | -169.04%(+38.8%) |
| Jun 2021 | - | -121.81%(-18.4%) |
| Mar 2021 | - | -149.32%(-16.4%) |
| Dec 2020 | -108.28%(-53.9%) | -178.61%(+1332.3%) |
| Sep 2020 | - | -12.47%(-95.4%) |
| Jun 2020 | - | -270.55%(+77.0%) |
| Mar 2020 | - | -152.81%(+46.8%) |
| Dec 2019 | -235.02%(-72.0%) | -104.08%(-81.4%) |
| Sep 2019 | - | -560.38%(+297.5%) |
| Jun 2019 | - | -140.98%(-80.6%) |
| Mar 2019 | - | -728.18%(-73.9%) |
| Dec 2018 | -838.76%(-5.5%) | - |
| Sep 2018 | - | -2788.89%(+103.8%) |
| Jun 2018 | -887.34%(+260.1%) | -1368.11%(+171.4%) |
| Mar 2018 | - | -504.09%(-19.0%) |
| Dec 2017 | - | -622.51%(-60.1%) |
| Sep 2017 | - | -1560.00%(+78.2%) |
| Jun 2017 | -246.40%(-81.7%) | -875.32%(+0.1%) |
| Mar 2017 | - | -874.58%(>+9900.0%) |
| Dec 2016 | - | -1.57%(-99.9%) |
| Sep 2016 | - | -2594.22%(+22.2%) |
| Jun 2016 | -1344.07%(-5660.9%) | -2123.68%(+35.0%) |
| Mar 2016 | - | -1572.84%(+57.9%) |
| Dec 2015 | - | -995.82%(-6.9%) |
| Sep 2015 | - | -1069.53%(-15.9%) |
| Jun 2015 | 24.17% | -1271.39%(-17.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | -1540.24%(+95.0%) |
| Dec 2014 | - | -790.02%(-1061.7%) |
| Sep 2014 | - | 82.15%(-106.0%) |
| Jun 2014 | -390.67%(-30.4%) | -1374.66%(+1131.8%) |
| Mar 2014 | - | -111.60%(-81.7%) |
| Dec 2013 | - | -610.30%(-2.0%) |
| Sep 2013 | - | -622.78%(-23.0%) |
| Jun 2013 | -561.41%(+90.7%) | -809.15%(+47.6%) |
| Mar 2013 | - | -548.15%(+21.1%) |
| Dec 2012 | - | -452.65%(-3.4%) |
| Sep 2012 | - | -468.35%(+41.7%) |
| Jun 2012 | -294.41%(+46.1%) | -330.47%(-34.8%) |
| Mar 2012 | - | -506.88%(+13.5%) |
| Dec 2011 | - | -446.51%(+192.7%) |
| Sep 2011 | - | -152.56%(+1740.3%) |
| Jun 2011 | -201.47%(-610.8%) | -8.29%(-99.0%) |
| Mar 2011 | - | -871.94%(+15.7%) |
| Dec 2010 | - | -753.86%(+4.5%) |
| Sep 2010 | - | -721.64%(-1032.0%) |
| Jun 2010 | 39.44%(-203.5%) | 77.43%(-113.9%) |
| Mar 2010 | - | -555.92%(>+9900.0%) |
| Dec 2009 | - | -3.29%(+4.1%) |
| Sep 2009 | - | -3.16%(+84.8%) |
| Jun 2009 | -38.12%(-94.7%) | -1.71%(-93.1%) |
| Mar 2009 | - | -24.69%(-48.4%) |
| Dec 2008 | - | -47.85%(-43.6%) |
| Sep 2008 | - | -84.78%(-54.6%) |
| Jun 2008 | -716.37%(-55.0%) | -186.57%(-84.7%) |
| Mar 2008 | - | -1219.37%(-80.6%) |
| Dec 2007 | - | -6278.13%(+24.0%) |
| Sep 2007 | - | -5061.17%(-38.3%) |
| Jun 2007 | -1590.25%(-15.8%) | -8202.64%(+390.2%) |
| Dec 2006 | - | -1673.23%(-76.2%) |
| Jun 2006 | -1889.15%(-18.9%) | -7019.82%(-33.1%) |
| Jun 2005 | -2330.58%(-0.9%) | -10.50 K%(-24.2%) |
| Jun 2004 | -2351.37%(-51.4%) | -13.84 K%(-8.3%) |
| Jun 2003 | -4838.64%(+1853.6%) | -15.10 K% |
| Jun 2002 | -247.68%(-67.1%) | - |
| Jun 2001 | -752.78% | - |
FAQ
- What is EyePoint Pharmaceuticals annual operating profit margin?
- What is the all time high annual operating margin for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual operating margin year-on-year change?
- What is EyePoint Pharmaceuticals quarterly operating profit margin?
- What is the all time high quarterly operating margin for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly operating margin year-on-year change?
What is EyePoint Pharmaceuticals annual operating profit margin?
The current annual operating margin of EYPT is -163.13%
What is the all time high annual operating margin for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual operating profit margin is 39.44%
What is EyePoint Pharmaceuticals annual operating margin year-on-year change?
Over the past year, EYPT annual operating profit margin has changed by +27.52% (+14.43%)
What is EyePoint Pharmaceuticals quarterly operating profit margin?
The current quarterly operating margin of EYPT is -311.17%
What is the all time high quarterly operating margin for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly operating profit margin is 82.15%
What is EyePoint Pharmaceuticals quarterly operating margin year-on-year change?
Over the past year, EYPT quarterly operating profit margin has changed by -216.46% (-228.55%)